These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28267648)

  • 1. Expression of soluble CD83 in plasma from early-stage rheumatoid arthritis patients is not modified by anti-TNF-α therapy.
    Kristensen AM; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Höllsberg P; Deleuran B; Hvid M
    Cytokine; 2017 Aug; 96():1-7. PubMed ID: 28267648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of the soluble forms of CD80, CD86, and CD83 are elevated in the synovial fluid of rheumatoid arthritis patients.
    Hock BD; O'Donnell JL; Taylor K; Steinkasserer A; McKenzie JL; Rothwell AG; Summers KL
    Tissue Antigens; 2006 Jan; 67(1):57-60. PubMed ID: 16451202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis.
    Capsoni F; Sarzi-Puttini P; Atzeni F; Minonzio F; Bonara P; Doria A; Carrabba M
    Arthritis Res Ther; 2005; 7(2):R250-5. PubMed ID: 15743471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
    Alivernini S; Tolusso B; Petricca L; Bui L; Di Sante G; Peluso G; Benvenuto R; Fedele AL; Federico F; Ferraccioli G; Gremese E
    Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eukaryotic expression of functionally active recombinant soluble CD83 from HEK 293T cells.
    Staab C; Mühl-Zürbes P; Steinkasserer A; Kummer M
    Immunobiology; 2010; 215(9-10):849-54. PubMed ID: 20576314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD206 plasma levels in rheumatoid arthritis reflect decrease in disease activity.
    Heftdal LD; Stengaard-Pedersen K; Ørnbjerg LM; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Hvid M; Deleuran B; Møller HJ; Greisen SR
    Scand J Clin Lab Invest; 2017 Sep; 77(5):385-389. PubMed ID: 28598681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease activity improvement in rheumatoid arthritis treated with tumor necrosis factor-α inhibitors correlates with increased soluble Fas levels.
    Romano E; Terenzi R; Manetti M; Peruzzi F; Fiori G; Nacci F; Bellando-Randone S; Matucci-Cerinic M; Guiducci S
    J Rheumatol; 2014 Oct; 41(10):1961-5. PubMed ID: 25179850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera.
    Hock BD; Kato M; McKenzie JL; Hart DN
    Int Immunol; 2001 Jul; 13(7):959-67. PubMed ID: 11431426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putative loss of CD83 immunosuppressive activity in long-standing complication-free juvenile diabetic patients during disease progression.
    Juhas U; Ryba-Stanisławowska M; Ławrynowicz U; Myśliwiec M; Myśliwska J
    Immunol Res; 2019 Feb; 67(1):70-76. PubMed ID: 30937729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD83 Triggers Resolution of Arthritis and Sustained Inflammation Control in IDO Dependent Manner.
    Royzman D; Andreev D; Stich L; Rauh M; Bäuerle T; Ellmann S; Boon L; Kindermann M; Peckert K; Bozec A; Schett G; Steinkasserer A; Zinser E
    Front Immunol; 2019; 10():633. PubMed ID: 31001257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis.
    Neidhart M; Wehrli R; Brühlmann P; Michel BA; Gay RE; Gay S
    Arthritis Rheum; 1999 Apr; 42(4):622-30. PubMed ID: 10211875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal Structure of the Extracellular Domain of the Human Dendritic Cell Surface Marker CD83.
    Heilingloh CS; Klingl S; Egerer-Sieber C; Schmid B; Weiler S; Mühl-Zürbes P; Hofmann J; Stump JD; Sticht H; Kummer M; Steinkasserer A; Muller YA
    J Mol Biol; 2017 Apr; 429(8):1227-1243. PubMed ID: 28315353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
    Mathsson L; Lampa J; Mullazehi M; Rönnelid J
    Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity.
    Tokayer A; Carsons SE; Chokshi B; Santiago-Schwarz F
    J Rheumatol; 2002 Mar; 29(3):454-61. PubMed ID: 11908556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment Response.
    Kragstrup TW; Jalilian B; Keller KK; Zhang X; Laustsen JK; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Hauge EM; Hvid M; Vorup-Jensen T; Deleuran B
    PLoS One; 2016; 11(2):e0148486. PubMed ID: 26849368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression and characterization of functionally active soluble CD83 by Pichia pastoris using high-density fermentation.
    Guo Y; Li R; Song X; Zhong Y; Wang C; Jia H; Wu L; Wang D; Fang F; Ma J; Kang W; Sun J; Tian Z; Xiao W
    PLoS One; 2014; 9(2):e89264. PubMed ID: 24586642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
    Cacciapaglia F; Anelli MG; Rinaldi A; Serafino L; Covelli M; Scioscia C; Iannone F; Lapadula G
    Drug Dev Res; 2014 Nov; 75 Suppl 1():S77-80. PubMed ID: 25381986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The levels of soluble forms of CD21 and CD83 in multiple sclerosis.
    Karampoor S; Zahednasab H; Etemadifar M; Keyvani H
    J Neuroimmunol; 2018 Jul; 320():11-14. PubMed ID: 29759135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early and late effect of infliximab on circulating dendritic cells phenotype in rheumatoid arthritis patients.
    Balanescu A; Radu E; Nat R; Regalia T; Bojinca V; Ionescu R; Balanescu S; Savu C; Predeteanu D
    Int J Clin Pharmacol Res; 2005; 25(1):9-18. PubMed ID: 15864873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha promotes the expression of osteoprotegerin in rheumatoid synovial fibroblasts.
    Kubota A; Hasegawa K; Suguro T; Koshihara Y
    J Rheumatol; 2004 Mar; 31(3):426-35. PubMed ID: 14994384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.